España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
NeuroMetrix
NURO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.00
-0.06
-1.48%
At close: -
$4.02
0.02
0.50%
After Hours: Jan 16, 8:24 AM EDT
Get Report
Comment
NeuroMetrix (NURO) Forecast
News
Earnings
NeuroMetrix (NURO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for NeuroMetrix (NASDAQ:NURO) Stock
NeuroMetrix Stock (NASDAQ: NURO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
Trading Halt: Halt status updated at 4:30:00 ...
Benzinga Newsdesk
electroCore Enters Definitive Deal To Acquire...
Benzinga Newsdesk
Trading Halt: Halted at 4:00:10 p.m. ET - Tra...
Benzinga Newsdesk
Tuesday, November 05, 2024
NeuroMetrix Reports Q3 2024 Sales Of $0.6M Vs...
Benzinga Newsdesk
Tuesday, August 13, 2024
NeuroMetrix Reiterates Its Review Of Strategi...
Benzinga Newsdesk
Tuesday, August 06, 2024
NeuroMetrix Q2 EPS $(0.74) Up From $(1.52) Yo...
Benzinga Newsdesk
Wednesday, May 15, 2024
NeuroMetrix Q1 EPS $(1.67) Down From $(1.64) ...
Benzinga Newsdesk
NeuroMetrix Q1 Revenue $1.093M Down From $1.7...
Benzinga Newsdesk
Friday, April 19, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
NeuroMetrix Appoints Joshua S. Horowitz As Ne...
Benzinga Newsdesk
Thursday, March 14, 2024
NeuroMetrix Publishes Study Demonstrating Tha...
Benzinga Newsdesk
Wednesday, March 13, 2024
NeuroMetrix Announces That Over 2000 Patients...
Benzinga Newsdesk
Monday, March 04, 2024
Echo Lake Capital Calls For The Liquidation O...
Benzinga Newsdesk
Thursday, February 22, 2024
NeuroMetrix Q4 EPS $(1.43) Down From $(0.73) ...
Benzinga Newsdesk
Earnings Scheduled For February 22, 2024
Benzinga Insights
Tuesday, February 20, 2024
NeuroMetrix 13G Filing Shows RS Fund LP Repor...
Benzinga Newsdesk
Tuesday, February 13, 2024
NeuroMetrix Announces Review Of Strategic Opt...
Benzinga Newsdesk
Tuesday, December 12, 2023
NeuroMetrix Reported The Recent Presentation ...
Benzinga Newsdesk
Tuesday, December 05, 2023
NeuroMetrix Announces Peer-Reviewed Publicati...
Benzinga Newsdesk
Wednesday, November 22, 2023
NeuroMetrix Shares Resume Trade
Benzinga Newsdesk
NeuroMetrix Shares To Resume Trade At 9:00 A....
Charles Gross
Monday, November 20, 2023
NeuroMetrix Announces 1-For-8 Reverse Stock S...
Benzinga Newsdesk
Friday, November 10, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, October 26, 2023
NeuroMetrix shares are trading lower after th...
Benzinga Newsdesk
Earnings Scheduled For October 26, 2023
Benzinga Insights
NeuroMetrix Q3 GAAP EPS $(0.21) Up From $(0.2...
Benzinga Newsdesk
Monday, October 02, 2023
NeuroMetrix And The National Fibromyalgia Ass...
Benzinga Newsdesk
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, August 28, 2023
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Wednesday, August 23, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, August 22, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, August 14, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Tuesday, August 01, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, July 27, 2023
NeuroMetrix Q2 EPS $(0.19) Down From $(0.17) ...
Benzinga Newsdesk
Earnings Scheduled For July 27, 2023
Benzinga Insights
Thursday, June 01, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, May 31, 2023
NeuroMetrix Shares Quell Clinical Trial Resul...
Benzinga Newsdesk
Monday, May 22, 2023
NeuroMetrix Granted European Patent Number EP...
Benzinga Newsdesk
Wednesday, May 03, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
NeuroMetrix shares are trading lower after th...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
NeuroMetrix Q1 EPS $(0.20) Down From $(0.14) ...
Benzinga Newsdesk
Tuesday, March 21, 2023
NeuroMetrix To Exhibit Quell Fibromyalgia And Present New Clinical Data At The American Academy Of Pain Medicine 2023 Annual Meeting
Happy Mohamed
Thursday, February 23, 2023
NeuroMetrix Q4 EPS $(0.09) Up From $(0.15) Yo...
Benzinga Newsdesk
Earnings Scheduled For February 23, 2023
Benzinga Insights
Wednesday, January 25, 2023
NeuroMetrix Received Decision To Grant European Patent Titled 'TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION USING NOVEL UNBALANCED BIPHASIC WAVEFORM AND NOVEL ELECTRODE ARRANGEMENT'
Michael Horton
Monday, January 23, 2023
NeuroMetrix Announces Launch Of DPNCheck 2.0,...
Benzinga Newsdesk
Wednesday, January 11, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, November 08, 2022
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
